Apellis Pharmaceuticals, Inc. (APLS)
23.86
+0.07
(+0.29%)
USD |
NASDAQ |
Dec 09, 10:57
Apellis Pharmaceuticals Total Liabilities (Quarterly): 657.56M for Sept. 30, 2025
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Biogen, Inc. | 11.00B |
| Amicus Therapeutics, Inc. | 638.39M |
| Fortress Biotech, Inc. | 116.22M |
| Ultragenyx Pharmaceutical, Inc. | 1.174B |
| Fulcrum Therapeutics, Inc. | 16.49M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 1.059B |
| Shareholders Equity (Quarterly) | 401.17M |
| Debt to Equity Ratio | 1.185 |
| Current Ratio | 3.544 |
| Net Debt Paydown Yield | -0.01% |